Faculty and Staff
Administration : Faculty, Research, and Courses : Academic Organizational Chart : Employment Opportunities
Publications of Raja S. Rachakatla, Ph.D.
|
|
| 12. | Shrestha TB, Seo GM, Basel MT, Kalita M, Wang H, Villanueva D, Pyle M, Balivada S, Rachakatla RS, Shinogle H, Thapa PS, Moore D, Troyer DL, Bossmann SH. Stem cell-based photodynamic therapy. Photochem Photobiol Sci. 2012 May 8. [Epub ahead of print] PubMed |
| 11. | Seo GM, Rachakatla RS, Balivada S, Pyle M, Shrestha TB, Basel MT, Myers C, Wang H, Tamura M, Bossmann SH, Troyer DL. A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma. Mol Biol Rep. 2012 Jan;39(1):157-65. Epub 2011 May 13. PubMed |
| 10. | Maurya DK, Doi C, Pyle M, Rachakatla RS, Davis D, Tamura M, Troyer D. Non-random tissue distribution of human naïve umbilical cord matrix stem cells. World J Stem Cells. 2011 Apr 26;3(4):34-42. PubMed |
9. |
Rachakatla RS, Balivada S, Seo GM, Myers CB, Wang H, Samarakoon TN, Dani R, Pyle M, Kroh FO, Walker B, Leaym X, Koper OB, Chikan V, Bossmann SH, Tamura M, Troyer DL. Attenuation of mouse melanoma by a/c magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. ACS Nano. 2010 Dec 28;4(12):7093-104. Epub 2010 Nov 8. PubMed. |
8. |
Balivada S, Rachakatla RS, Wang H, Samarakoon TN, Dani RK, Pyle M, Kroh FO, Walker B, Leaym X, Koper OB, Tamura M, Chikan V, Bossmann SH, Troyer DL. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study. BMC Cancer. 2010 Mar 30;10:119. PubMed |
7. |
Matsuzuka T, Rachakatla RS, Doi C, Maurya DK, Ohta N, Kawabata A, Pyle MM, Pickel L, Reischman J, Marini F, Troyer D, Tamura M. Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice.Lung Cancer. 2010 Oct;70(1):28-36. [Epub ahead of print]. PubMed |
6. |
Ayuzawa R, Doi C, Rachakatla RS, Pyle MM, Maurya DK, Troyer D, Tamura M. Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett. 2009 Jul 18;280(1):31-7. Epub 2009 Mar 13. PubMed |
5. |
Rachakatla RS, Troyer D. Wharton's jelly stromal cells as potential delivery vehicles for cancer therapeutics. Future Oncol. 2009 Oct;5(8):1237-44. Review. PubMed |
4. |
Ganta C, Chiyo D, Ayuzawa R, Rachakatla R, Pyle M, Andrews G, Weiss M, Tamura M, Troyer D. Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res. 2009 Mar 1;69(5):1815-20. Epub 2009 Feb 24. PubMed |
3. |
Rachakatla RS, Pyle MM, Ayuzawa R, Edwards SM, Marini FC, Weiss ML, Tamura M, Troyer D. Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs. Cancer Invest. 2008 Aug;26(7):662-70. PubMed |
2. |
Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2006 Mar;24(3):781-92. Epub 2005 Oct 13. PubMed |
1. |
Rachakatla RS, Marini F, Weiss ML, Tamura M, Troyer D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther. 2007 Oct;14(10):828-35. Epub 2007 Jun 29. PubMed |
| Books Return to top | |
|
|
